ProCE Banner Activity

How I Use Incretin-Based Therapy to Address Obesity and Cardiovascular Disease

Clinical Thought

The benefit I see with incretin therapy in my patients with type 2 diabetes is profound. Here are my thoughts about incorporating these medications into your armamentarium to address obesity and cardiovascular disease.

Released: January 09, 2023

Expiration: January 08, 2024

Share

Faculty

Lisa Coco

Lisa Coco, MSN, CRNP, CDCES

Nurse Practitioner
Department of Endocrinology
Jefferson University
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Novo Nordisk

Faculty Disclosure

Primary Author

Lisa Coco, MSN, CRNP, CDCES

Nurse Practitioner
Department of Endocrinology
Jefferson University
Philadelphia, Pennsylvania

Lisa Coco, MSN, CRNP, CDCES: consultant/advisor/speaker: AstraZeneca, Novo Nordisk, Xeris.